trending Market Intelligence /marketintelligence/en/news-insights/trending/YzNQ5BvxnIh0JPe2gxeILQ2 content esgSubNav
In This List

Merrimack appoints president, CEO

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Merrimack appoints president, CEO

Merrimack Pharmaceuticals Inc. appointed Richard Peters as its president and CEO, effective Feb. 6.

Peters will also be appointed a director on the same day. The appointee currently serves as senior vice president and head of global rare diseases at Sanofi Genzyme, a Sanofi subsidiary.

Merrimack's interim president and CEO, Gary Crocker, will continue to serve as the chairman of the board.